Product NDC: | 0904-1315 |
Proprietary Name: | Bismatrol |
Non Proprietary Name: | Bismuth subsalicylate |
Active Ingredient(s): | 262 mg/1 & nbsp; Bismuth subsalicylate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, CHEWABLE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0904-1315 |
Labeler Name: | Major Pharmaceuticals |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part335 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20030103 |
Package NDC: | 0904-1315-46 |
Package Description: | 5 BLISTER PACK in 1 CARTON (0904-1315-46) > 6 TABLET, CHEWABLE in 1 BLISTER PACK |
NDC Code | 0904-1315-46 |
Proprietary Name | Bismatrol |
Package Description | 5 BLISTER PACK in 1 CARTON (0904-1315-46) > 6 TABLET, CHEWABLE in 1 BLISTER PACK |
Product NDC | 0904-1315 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Bismuth subsalicylate |
Dosage Form Name | TABLET, CHEWABLE |
Route Name | ORAL |
Start Marketing Date | 20030103 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Major Pharmaceuticals |
Substance Name | BISMUTH SUBSALICYLATE |
Strength Number | 262 |
Strength Unit | mg/1 |
Pharmaceutical Classes |